PureTech Health plc
PTCHF
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.23B
Close$
Share Statistics
| Market cap | $4.23 Billion |
|---|---|
| Enterprise Value | $4.00 Billion |
| Dividend Yield | $NaN (NaN%) |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -17.94% |
|---|---|
| Return on Assets | -10.47% |
| Return on Invested Capital | -13.21% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 445.88 |
| Enterprise Value to EBIT | -61.94 |
| Enterprise Value to Net Income | -72 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 22, 2026
EPS Estimate
$-0.12
Average shareholder expectationRevenue Estimate
$24.80 M
Average shareholder expectationNext Earnings Call
Expected Date
April 29, 2027
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$24.80 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PureTech Health Plc
66 employees
CEO: Daphne Zohar PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurologic...